Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20
Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov, Mark Primeaux, Kurt W. Fisher, Amar B. Singh, Punita Dhawan
Topics & Concepts
OxaliplatinMedicineColorectal cancerPharmacologyIn vivoIrinotecanDrug resistanceCancerAlbendazoleDrugCancer researchOncologyInternal medicineBiologySurgeryBiotechnologyMicrobiologyCancer Cells and MetastasisCancer, Stress, Anesthesia, and Immune ResponsePI3K/AKT/mTOR signaling in cancer